Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers (Q34001071)

30 July 2017

Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers (English)

1 reference

30 July 2017

information processing

1 reference

Elke Wezenberg

1

1 reference

30 July 2017

Robert Jan Verkes

2

1 reference

30 July 2017

Ge S F Ruigt

3

1 reference

30 July 2017

Wouter Hulstijn

4

1 reference

30 July 2017

Bernard G C Sabbe

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

22 November 2006

1 reference

30 July 2017

Neuropsychopharmacology

1 reference

30 July 2017

32

1 reference

30 July 2017

1272-1283

1 reference

30 July 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301257

30 July 2017

0 references

cites work

Effect of distribution of practice on rotary pursuit "hits"

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

A centrally active drug that modulates AMPA receptor gated currents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Performance Evaluation Tests for Environmental Research (PETER): evaluation of 114 measures.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

The use of analogue scales in rating subjective feelings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Cognitive Processes and Self-regulation: Determinants of Concentration and Distraction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Can specific deficits in executive functioning explain the negative symptoms of schizophrenia? A review.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Glucose and memory: fractionation of enhancement effects?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Changes in memory processing with age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Facilitation of glutamate receptors reverses an age-associated memory impairment in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Facilitative effects of the ampakine CX516 on short-term memory in rats: enhancement of delayed-nonmatch-to-sample performance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Pharmacokinetic-dynamic study on different oral biperiden formulations in volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Enhancement by an ampakine of memory encoding in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Psychomotor slowing and planning deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Facilitation of olfactory learning by a modulator of AMPA receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Effects of S 18986-1, a novel cognitive enhancer, on memory performances in an object recognition task in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Aging of the brain, sensorimotor, and cognitive processes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

AMPA receptor modulators as cognitive enhancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Memory and the brain: unexpected chemistries and a new pharmacology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Reversible cognitive decline accompanies migraine and cluster headaches.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Evidence for abnormal cortical functional connectivity during working memory in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Identification of separable cognitive factors in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Dopamine-antagonistic, anticholinergic, and GABAergic effects on declarative and procedural memory functions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Retardation in depression: assessment by means of simple motor tasks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Restoration of spatial working memory by genetic rescue of GluR-A-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Enhanced glutamatergic neurotransmission facilitates classical conditioning in the freely moving rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

D-amphetamine challenge effects on Wisconsin Card Sort Test. Performance in schizotypal personality disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Facilitation of glutamate receptors enhances memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Rey Auditory-Verbal Learning Test: structure analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Differentiation of cognitive and motor slowing in the Digit Symbol Test (DST): differences between depression and schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Changes in brain activity during motor learning measured with PET: effects of hand of performance and practice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

fMRI applications in schizophrenia research.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301257

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301257

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference